On Mar. 27, 2023, CIRM Board approved investing nearly $26 million in 17 projects in early-stage discovery research.The awards were from CIRMﾒs DISC-0: Foundation Awards Program, which supports rigorous studies addressing critical basic knowledge gaps in the biology of stem cells and regenerative medicine approaches and to advance stem cell-based tools.